首页 正文

Pharmacotherapies of NAFLD: updated opportunities based on metabolic intervention

{{output}}
Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease that is becoming increasingly prevalent, and it ranges from simple steatosis to cirrhosis. However, there is still a lack of pharmacotherapeutic strategies approved by the Food and Drug Admin... ...